Literature DB >> 30590054

Engineering an Environment for the Study of Fibrosis: A 3D Human Muscle Model with Endothelium Specificity and Endomysium.

Simone Bersini1, Mara Gilardi2, Giovanni S Ugolini3, Veronica Sansoni4, Giuseppe Talò1, Silvia Perego4, Simona Zanotti5, Paola Ostano6, Marina Mora5, Monica Soncini3, Marco Vanoni7, Giovanni Lombardi4, Matteo Moretti8.   

Abstract

The integration of vascular structures into in vitro cultured tissues provides realistic models of complex tissue-vascular interactions. Despite the incidence and impact of muscle-wasting disorders, advanced in vitro systems are still far from recapitulating the environmental complexity of skeletal muscle. Our model comprises differentiated human muscle fibers enveloped by a sheath of human muscle-derived fibroblasts and supported by a vascular network with mural-like cells. Here, we demonstrate the induction of muscle-specific endothelium and the self-organization of endomysial muscle fibroblasts mediated by endothelial cells. We use this model to mimic the fibrotic environment characterizing muscular dystrophies and to highlight key signatures of fibrosis that are neglected or underestimated in traditional 2D monocultures. Overall, this vascularized meso-scale cellular construct finely recapitulates the human skeletal muscle environment and provides an advanced solution for in vitro studies of muscle physiology and pathology.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D vascularized muscle model; endothelial specificity; fibrosis; muscle environment

Mesh:

Year:  2018        PMID: 30590054     DOI: 10.1016/j.celrep.2018.11.092

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  20 in total

Review 1.  Building Complex Life Through Self-Organization.

Authors:  Mireille M J P E Sthijns; Vanessa L S LaPointe; Clemens A van Blitterswijk
Journal:  Tissue Eng Part A       Date:  2019-09-20       Impact factor: 3.845

2.  From arteries to capillaries: approaches to engineering human vasculature.

Authors:  Sharon Fleischer; Daniel Naveed Tavakol; Gordana Vunjak-Novakovic
Journal:  Adv Funct Mater       Date:  2020-06-11       Impact factor: 18.808

3.  Can we mimic skeletal muscles for novel drug discovery?

Authors:  Torie Broer; Alastair Khodabukus; Nenad Bursac
Journal:  Expert Opin Drug Discov       Date:  2020-03-03       Impact factor: 6.098

4.  Human Tissue-Engineered Skeletal Muscle: A Tool for Metabolic Research.

Authors:  Ji-Hoon Kim; Seung-Min Yu; Jang Won Son
Journal:  Endocrinol Metab (Seoul)       Date:  2022-06-29

5.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

6.  Biofabrication of 3D Human Muscle Model with Vascularization and Endomysium.

Authors:  Simone Bersini; Riccardo Francescato; Matteo Moretti
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Fabrication approaches for high-throughput and biomimetic disease modeling.

Authors:  Mackenzie L Grubb; Steven R Caliari
Journal:  Acta Biomater       Date:  2021-03-11       Impact factor: 10.633

Review 8.  Cored in the act: the use of models to understand core myopathies.

Authors:  Aurora Fusto; Louise A Moyle; Penney M Gilbert; Elena Pegoraro
Journal:  Dis Model Mech       Date:  2019-12-19       Impact factor: 5.758

9.  Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodeling.

Authors:  Simone Bersini; Nikki K Lytle; Roberta Schulte; Ling Huang; Geoffrey M Wahl; Martin W Hetzer
Journal:  Life Sci Alliance       Date:  2020-01-20

10.  Neural cell integration into 3D bioprinted skeletal muscle constructs accelerates restoration of muscle function.

Authors:  Ji Hyun Kim; Ickhee Kim; Young-Joon Seol; In Kap Ko; James J Yoo; Anthony Atala; Sang Jin Lee
Journal:  Nat Commun       Date:  2020-02-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.